(19)
(11) EP 2 531 185 A2

(12)

(43) Date of publication:
12.12.2012 Bulletin 2012/50

(21) Application number: 11740231.3

(22) Date of filing: 31.01.2011
(51) International Patent Classification (IPC): 
A61K 31/16(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2011/023154
(87) International publication number:
WO 2011/097166 (11.08.2011 Gazette 2011/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 02.02.2010 US 300643 P

(71) Applicant: Board of Regents, The University of Texas System
Austin, TX 78701 (US)

(72) Inventor:
  • LEE, Ho-Young
    Austin, TX 78701 (US)

(74) Representative: Horgan, James Michael Frederic et al
Merck & Co., Inc. European Patent Department Merck Sharpe & Dohme Limited Hertford Road
Hoddesdon Hertfordshire EN11 9BU
Hoddesdon Hertfordshire EN11 9BU (GB)

   


(54) COMBINATION THERAPY FOR TREATING CANCER COMPRISING AN IGF-1R INHIBITOR AND AN HDAC INHIBITOR